(-)-anisomycin increases expression ISO RGD:732141 6480464 Anisomycin results in increased expression of TXNIP mRNA CTD PMID:10843682 (-)-demecolcine increases expression ISO RGD:1343574 6480464 Demecolcine results in increased expression of TXNIP mRNA CTD PMID:23649840 (S)-nicotine increases expression ISO RGD:732141 6480464 Nicotine results in increased expression of TXNIP mRNA CTD PMID:17456735 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:1343574 6480464 o, p'-DDT results in decreased expression of TXNIP mRNA CTD PMID:19371625 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of TXNIP protein CTD PMID:17337753 1,2-dimethylhydrazine decreases expression ISO RGD:732141 6480464 1, 2-Dimethylhydrazine results in decreased expression of TXNIP mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of TXNIP mRNA CTD PMID:20551477 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of TXNIP mRNA CTD PMID:17351261 17beta-estradiol multiple interactions ISO RGD:1343574 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TXNIP mRNA more ... CTD PMID:19619570 , PMID:34318539 17beta-estradiol decreases expression ISO RGD:1343574 6480464 Estradiol results in decreased expression of TXNIP mRNA CTD PMID:31614463 17beta-estradiol decreases expression ISO RGD:732141 6480464 Estradiol results in decreased expression of TXNIP mRNA CTD PMID:25575267 17beta-estradiol increases expression ISO RGD:1343574 6480464 Estradiol results in increased expression of TXNIP mRNA CTD PMID:19619570 , PMID:21185374 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:1343574 6480464 2 more ... CTD PMID:20638727 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1343574 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1343574 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TXNIP mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TXNIP mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TXNIP mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732141 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TXNIP mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732141 6480464 Tetrachlorodibenzodioxin affects the expression of TXNIP mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732141 6480464 Tetrachlorodibenzodioxin results in decreased expression of TXNIP mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1343574 6480464 Tetrachlorodibenzodioxin results in increased expression of TXNIP mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TXNIP mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1343574 6480464 Tetrachlorodibenzodioxin results in decreased expression of TXNIP mRNA CTD PMID:19619570 , PMID:19692669 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:1343574 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of TXNIP mRNA CTD PMID:21346803 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP mRNA], Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP protein] CTD PMID:35460826 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of TXNIP protein CTD PMID:17178593 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:732141 6480464 Glucosamine results in increased expression of TXNIP mRNA, Glucosamine results in increased expression of TXNIP protein CTD PMID:17178593 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:732141 6480464 Glucosamine promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:17178593 2-hydroxypropanoic acid increases expression ISO RGD:1343574 6480464 Lactic Acid results in increased expression of TXNIP mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1343574 6480464 3 more ... CTD PMID:19692669 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:732141 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:732141 6480464 tetrabromobisphenol A results in decreased expression of TXNIP mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO RGD:732141 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of TXNIP mRNA CTD PMID:20188158 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of TXNIP mRNA CTD PMID:28522335 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of TXNIP mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases expression ISO RGD:1343574 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of TXNIP mRNA CTD PMID:25912373 4-hydroxyphenyl retinamide decreases expression ISO RGD:732141 6480464 Fenretinide results in decreased expression of TXNIP mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1343574 6480464 Decitabine affects the expression of TXNIP mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO RGD:1343574 6480464 Decitabine results in increased expression of TXNIP mRNA CTD PMID:19194470 5-fluorouracil multiple interactions ISO RGD:1343574 6480464 [allose co-treated with Fluorouracil] results in increased expression of TXNIP protein more ... CTD PMID:15016801 , PMID:18930000 5-fluorouracil affects response to substance ISO RGD:1343574 6480464 TXNIP protein affects the susceptibility to Fluorouracil CTD PMID:15548681 5-fluorouracil increases expression ISO RGD:1343574 6480464 Fluorouracil results in increased expression of TXNIP mRNA CTD PMID:18930000 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TXNIP mRNA CTD PMID:24780913 6alpha-methylprednisolone increases expression ISO RGD:1343574 6480464 Methylprednisolone results in increased expression of TXNIP mRNA CTD PMID:19192274 7,12-dimethyltetraphene increases expression ISO RGD:732141 6480464 9 more ... CTD PMID:32553695 7,8-Diacetoxy-4-methylcoumarin decreases expression ISO RGD:1343574 6480464 7, 8-diacetoxy-4-methylcoumarin results in decreased expression of TXNIP mRNA CTD PMID:24103856 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of TXNIP protein CTD PMID:33236894 acrylamide decreases expression ISO RGD:1343574 6480464 Acrylamide results in decreased expression of TXNIP mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1343574 6480464 Aflatoxin B1 affects the expression of TXNIP protein CTD PMID:20106945 aflatoxin B1 multiple interactions ISO RGD:732141 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in increased expression of TXNIP mRNA] CTD PMID:35063475 aflatoxin B1 multiple interactions ISO RGD:1343574 6480464 [Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in increased expression of TXNIP mRNA CTD PMID:31904472 aflatoxin B1 increases expression ISO RGD:732141 6480464 Aflatoxin B1 results in increased expression of TXNIP mRNA CTD PMID:19770486 , PMID:35063475 aflatoxin B1 increases expression ISO RGD:1343574 6480464 Aflatoxin B1 results in increased expression of TXNIP mRNA CTD PMID:21632981 Aflatoxin B2 alpha multiple interactions ISO RGD:1343574 6480464 [Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in increased expression of TXNIP mRNA CTD PMID:31904472 Aflatoxin G1 multiple interactions ISO RGD:1343574 6480464 [Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in increased expression of TXNIP mRNA CTD PMID:31904472 Aflatoxin G2 multiple interactions ISO RGD:1343574 6480464 [Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in increased expression of TXNIP mRNA CTD PMID:31904472 AICA ribonucleotide multiple interactions ISO RGD:732141 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein] CTD PMID:29031535 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of TXNIP protein CTD PMID:17178593 aldehydo-D-glucosamine increases expression ISO RGD:732141 6480464 Glucosamine results in increased expression of TXNIP mRNA, Glucosamine results in increased expression of TXNIP protein CTD PMID:17178593 aldehydo-D-glucosamine multiple interactions ISO RGD:732141 6480464 Glucosamine promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:17178593 aldehydo-D-glucose increases expression ISO RGD:1343574 6480464 Glucose results in increased expression of TXNIP protein CTD PMID:23647015 aldehydo-D-glucose increases expression ISO RGD:732141 6480464 Glucose results in increased expression of TXNIP mRNA, Glucose results in increased expression of TXNIP protein CTD PMID:17178593 more ... aldehydo-D-glucose increases activity EXP 6480464 Glucose results in increased activity of TXNIP mRNA CTD PMID:21832250 aldehydo-D-glucose decreases expression ISO RGD:1343574 6480464 Glucose deficiency results in decreased expression of TXNIP mRNA, Glucose deficiency results in decreased expression of TXNIP protein CTD PMID:20195491 aldehydo-D-glucose multiple interactions ISO RGD:732141 6480464 [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein more ... CTD PMID:17178593 more ... aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of TXNIP protein CTD PMID:17178593 more ... aldehydo-D-glucose multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 , PMID:29031534 aldehydo-D-glucose increases response to substance ISO RGD:1343574 6480464 TXNIP mRNA results in increased susceptibility to Glucose CTD PMID:23647015 aldehydo-D-glucose multiple interactions ISO RGD:1343574 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 aldehydo-D-glucose increases response to substance EXP 6480464 TXNIP mRNA results in increased susceptibility to Glucose CTD PMID:23647015 all-trans-retinoic acid increases expression ISO RGD:1343574 6480464 Tretinoin results in increased expression of TXNIP mRNA CTD PMID:33167477 allopurinol multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Fructose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 , PMID:24491314 allopurinol multiple interactions ISO RGD:1343574 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] CTD PMID:23647015 allose multiple interactions ISO RGD:1343574 6480464 [allose co-treated with Fluorouracil] results in increased expression of TXNIP protein, Fluorouracil promotes the reaction [allose results in increased expression of TXNIP mRNA] CTD PMID:18930000 allose increases expression ISO RGD:1343574 6480464 allose results in increased expression of TXNIP mRNA, allose results in increased expression of TXNIP protein CTD PMID:18930000 alpha-D-galactose multiple interactions ISO RGD:1343574 6480464 Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]], Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein] CTD PMID:29426000 alpha-D-galactose increases expression ISO RGD:1343574 6480464 Galactose results in increased expression of TXNIP protein CTD PMID:29426000 AM-251 increases expression ISO RGD:1343574 6480464 AM 251 results in increased expression of TXNIP mRNA CTD PMID:16500647 anthocyanin multiple interactions ISO RGD:732141 6480464 Anthocyanins inhibits the reaction [Dietary Fats results in increased expression of TXNIP protein] CTD PMID:24795233 antimycin A decreases expression ISO RGD:1343574 6480464 Antimycin A results in decreased expression of TXNIP mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:1343574 6480464 aristolochic acid I results in decreased expression of TXNIP mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1343574 6480464 Arsenic affects the methylation of TXNIP gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1343574 6480464 Arsenic affects the methylation of TXNIP gene CTD PMID:25304211 arsenous acid decreases expression ISO RGD:1343574 6480464 Arsenic Trioxide results in decreased expression of TXNIP mRNA CTD PMID:15725085 more ... ATP increases activity EXP 6480464 Adenosine Triphosphate results in increased activity of TXNIP mRNA CTD PMID:21832250 atrazine increases expression ISO RGD:1343574 6480464 Atrazine results in increased expression of TXNIP mRNA CTD PMID:22378314 azathioprine increases expression ISO RGD:1343574 6480464 Azathioprine results in increased expression of TXNIP mRNA CTD PMID:19192274 azoxystrobin decreases expression ISO RGD:1343574 6480464 azoxystrobin results in decreased expression of TXNIP mRNA CTD PMID:33512557 baicalin multiple interactions ISO RGD:732141 6480464 baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein], dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]] CTD PMID:29031535 barium sulfate decreases expression EXP 6480464 Barium Sulfate results in decreased expression of TXNIP mRNA CTD PMID:29463257 beauvericin increases expression ISO RGD:1343574 6480464 beauvericin results in increased expression of TXNIP mRNA CTD PMID:29203277 beauvericin decreases expression ISO RGD:1343574 6480464 beauvericin results in decreased expression of TXNIP mRNA CTD PMID:34015425 beauvericin multiple interactions ISO RGD:1343574 6480464 [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA more ... CTD PMID:34015425 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of TXNIP mRNA CTD PMID:17905399 benzo[a]pyrene increases expression ISO RGD:1343574 6480464 Benzo(a)pyrene results in increased expression of TXNIP mRNA CTD PMID:17879257 more ... benzo[a]pyrene affects methylation ISO RGD:1343574 6480464 Benzo(a)pyrene affects the methylation of TXNIP exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:732141 6480464 Benzo(a)pyrene results in increased expression of TXNIP mRNA CTD PMID:22228805 , PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:732141 6480464 Benzo(a)pyrene results in decreased expression of TXNIP mRNA CTD PMID:19770486 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of TXNIP protein CTD PMID:17178593 beta-D-glucosamine increases expression ISO RGD:732141 6480464 Glucosamine results in increased expression of TXNIP mRNA, Glucosamine results in increased expression of TXNIP protein CTD PMID:17178593 beta-D-glucosamine multiple interactions ISO RGD:732141 6480464 Glucosamine promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:17178593 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 4 more ... CTD PMID:35460826 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of TXNIP mRNA, Diethylhexyl Phthalate results in increased expression of TXNIP protein CTD PMID:35460826 bisphenol A increases expression ISO RGD:732141 6480464 bisphenol A results in increased expression of TXNIP mRNA CTD PMID:26063408 bisphenol A increases expression ISO RGD:1343574 6480464 bisphenol A results in increased expression of TXNIP mRNA CTD PMID:29275510 bisphenol A decreases expression ISO RGD:732141 6480464 bisphenol A results in decreased expression of TXNIP mRNA CTD PMID:29161229 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TXNIP mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A decreases expression ISO RGD:1343574 6480464 bisphenol A results in decreased expression of TXNIP mRNA CTD PMID:25912373 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TXNIP mRNA CTD PMID:25181051 butan-1-ol multiple interactions ISO RGD:1343574 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXNIP mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1343574 6480464 butyraldehyde results in increased expression of TXNIP mRNA CTD PMID:26079696 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of TXNIP mRNA CTD PMID:12800193 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of TXNIP mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:1343574 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TXNIP mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNIP mRNA CTD PMID:31738976 , PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1343574 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TXNIP mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNIP mRNA CTD PMID:31738976 , PMID:35301059 calciol increases expression ISO RGD:1343574 6480464 Cholecalciferol results in increased expression of TXNIP mRNA, Cholecalciferol results in increased expression of TXNIP protein CTD PMID:20713078 , PMID:24451003 calcitriol multiple interactions ISO RGD:1343574 6480464 [Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein, Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein] CTD PMID:10843682 calcitriol increases expression ISO RGD:1343574 6480464 Calcitriol results in increased expression of TXNIP mRNA CTD PMID:10843682 calcitriol decreases expression ISO RGD:1343574 6480464 Calcitriol results in decreased expression of TXNIP mRNA CTD PMID:16002434 cannabidiol decreases expression ISO RGD:1343574 6480464 Cannabidiol results in decreased expression of TXNIP mRNA CTD PMID:33244087 capsaicin decreases expression ISO RGD:1343574 6480464 Capsaicin results in decreased expression of TXNIP mRNA CTD PMID:33512557 carbamazepine affects expression ISO RGD:1343574 6480464 Carbamazepine affects the expression of TXNIP mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1343574 6480464 Nanotubes, Carbon analog results in decreased expression of TXNIP mRNA CTD PMID:25102311 carbon nanotube decreases expression ISO RGD:732141 6480464 Nanotubes more ... CTD PMID:25554681 celastrol decreases expression ISO RGD:1343574 6480464 celastrol results in decreased expression of TXNIP mRNA CTD PMID:17010675 ceric oxide decreases expression EXP 6480464 ceric oxide results in decreased expression of TXNIP mRNA CTD PMID:29463257 CGP 52608 multiple interactions ISO RGD:1343574 6480464 CGP 52608 promotes the reaction [RORA protein binds to TXNIP gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:732141 6480464 Chlordecone results in increased expression of TXNIP mRNA CTD PMID:33711761 chloropicrin affects expression ISO RGD:1343574 6480464 chloropicrin affects the expression of TXNIP mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:732141 6480464 Chlorpyrifos results in decreased expression of TXNIP mRNA CTD PMID:34289071 ciguatoxin CTX1B affects expression ISO RGD:732141 6480464 Ciguatoxins affects the expression of TXNIP mRNA CTD PMID:18353800 Cinobufagin increases expression ISO RGD:1343574 6480464 cinobufagin results in increased expression of TXNIP mRNA CTD PMID:35447139 cisplatin increases expression ISO RGD:1343574 6480464 Cisplatin results in increased expression of TXNIP mRNA CTD PMID:27594783 cisplatin affects expression ISO RGD:1343574 6480464 Cisplatin affects the expression of TXNIP mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:732141 6480464 Cisplatin results in increased expression of TXNIP mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:1343574 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TXNIP mRNA, Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNIP mRNA] CTD PMID:21858171 , PMID:27392435 clofibrate decreases expression ISO RGD:732141 6480464 Clofibrate results in decreased expression of TXNIP mRNA CTD PMID:17585979 , PMID:25270620 clofibrate increases expression ISO RGD:732141 6480464 Clofibrate results in increased expression of TXNIP mRNA CTD PMID:23811191 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of TXNIP mRNA CTD PMID:12851107 Clofop multiple interactions ISO RGD:1343574 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of TXNIP mRNA CTD PMID:16197558 cobalt dichloride decreases expression ISO RGD:1343574 6480464 cobaltous chloride results in decreased expression of TXNIP mRNA CTD PMID:19320972 cobalt dichloride decreases expression ISO RGD:732141 6480464 cobaltous chloride results in decreased expression of TXNIP mRNA CTD PMID:21139344 colforsin daropate hydrochloride increases activity EXP 6480464 Colforsin results in increased activity of TXNIP mRNA CTD PMID:21832250 copper atom multiple interactions ISO RGD:1343574 6480464 [NSC 689534 binds to Copper] which results in increased expression of TXNIP mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1343574 6480464 [NSC 689534 binds to Copper] which results in increased expression of TXNIP mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1343574 6480464 Copper Sulfate results in increased expression of TXNIP mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1343574 6480464 coumarin results in increased phosphorylation of TXNIP protein CTD PMID:35688186 crocidolite asbestos multiple interactions ISO RGD:1343574 6480464 [Asbestos, Crocidolite results in increased oxidation of TXN protein] inhibits the reaction [TXN protein binds to TXNIP protein] CTD PMID:24885895 crocidolite asbestos decreases expression ISO RGD:732141 6480464 Asbestos, Crocidolite results in decreased expression of TXNIP mRNA CTD PMID:29279043 crotonaldehyde decreases expression ISO RGD:1343574 6480464 2-butenal results in decreased expression of TXNIP mRNA CTD PMID:20471460 curcumin multiple interactions ISO RGD:732141 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in increased expression of TXNIP mRNA] CTD PMID:35063475 cyclophosphamide multiple interactions ISO RGD:732141 6480464 ganoderic acid A inhibits the reaction [Cyclophosphamide results in increased expression of TXNIP protein] CTD PMID:30506662 cyclophosphamide increases expression ISO RGD:732141 6480464 Cyclophosphamide results in increased expression of TXNIP protein CTD PMID:30506662 cyclosporin A affects expression ISO RGD:1343574 6480464 Cyclosporine affects the expression of TXNIP mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1343574 6480464 Cyclosporine results in increased expression of TXNIP mRNA, Cyclosporine results in increased expression of TXNIP protein CTD PMID:21632981 , PMID:22147139 cyclosporin A decreases expression ISO RGD:1343574 6480464 Cyclosporine results in decreased expression of TXNIP mRNA CTD PMID:19159671 cyclosporin A multiple interactions ISO RGD:1343574 6480464 U 0126 inhibits the reaction [Cyclosporine results in increased expression of TXNIP protein] CTD PMID:22147139 cyclosporin A increases expression ISO RGD:732141 6480464 Cyclosporine results in increased expression of TXNIP mRNA CTD PMID:25270620 cypermethrin increases expression ISO RGD:732141 6480464 cypermethrin results in increased expression of TXNIP mRNA CTD PMID:21142847 cypermethrin decreases expression ISO RGD:732141 6480464 cypermethrin results in decreased expression of TXNIP mRNA CTD PMID:29020013 D-glucose increases response to substance EXP 6480464 TXNIP mRNA results in increased susceptibility to Glucose CTD PMID:23647015 D-glucose increases expression ISO RGD:732141 6480464 Glucose results in increased expression of TXNIP mRNA, Glucose results in increased expression of TXNIP protein CTD PMID:17178593 more ... D-glucose decreases expression ISO RGD:1343574 6480464 Glucose deficiency results in decreased expression of TXNIP mRNA, Glucose deficiency results in decreased expression of TXNIP protein CTD PMID:20195491 D-glucose multiple interactions ISO RGD:732141 6480464 [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein more ... CTD PMID:17178593 more ... D-glucose increases activity EXP 6480464 Glucose results in increased activity of TXNIP mRNA CTD PMID:21832250 D-glucose increases expression EXP 6480464 Glucose results in increased expression of TXNIP protein CTD PMID:17178593 more ... D-glucose multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 , PMID:29031534 D-glucose increases response to substance ISO RGD:1343574 6480464 TXNIP mRNA results in increased susceptibility to Glucose CTD PMID:23647015 D-glucose multiple interactions ISO RGD:1343574 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 D-glucose increases expression ISO RGD:1343574 6480464 Glucose results in increased expression of TXNIP protein CTD PMID:23647015 deguelin decreases expression ISO RGD:1343574 6480464 deguelin results in decreased expression of TXNIP mRNA CTD PMID:33512557 dehydroepiandrosterone decreases expression ISO RGD:1343574 6480464 Dehydroepiandrosterone results in decreased expression of TXNIP protein CTD PMID:20195491 dehydroepiandrosterone decreases expression ISO RGD:732141 6480464 Dehydroepiandrosterone results in decreased expression of TXNIP protein CTD PMID:20195491 dexamethasone increases expression ISO RGD:1343574 6480464 Dexamethasone results in increased expression of TXNIP mRNA CTD PMID:12782123 dexamethasone increases expression ISO RGD:732141 6480464 Dexamethasone results in increased expression of TXNIP mRNA CTD PMID:22733784 diallyl trisulfide multiple interactions ISO RGD:1343574 6480464 TXN protein promotes the reaction [diallyl trisulfide results in increased expression of TXNIP protein] CTD PMID:30396169 diallyl trisulfide increases expression ISO RGD:1343574 6480464 diallyl trisulfide results in increased expression of TXNIP protein CTD PMID:30396169 diarsenic trioxide decreases expression ISO RGD:1343574 6480464 Arsenic Trioxide results in decreased expression of TXNIP mRNA CTD PMID:15725085 more ... dibutyl phthalate decreases expression ISO RGD:732141 6480464 Dibutyl Phthalate results in decreased expression of TXNIP mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:732141 6480464 Dichloroacetic Acid results in increased expression of TXNIP mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:1343574 6480464 Diclofenac results in increased expression of TXNIP mRNA CTD PMID:19192274 dieldrin decreases expression ISO RGD:1343574 6480464 Dieldrin results in decreased expression of TXNIP mRNA CTD PMID:31068361 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of TXNIP mRNA CTD PMID:21161181 difenoconazole decreases expression EXP 6480464 difenoconazole results in decreased expression of TXNIP mRNA CTD PMID:28263823 dioxygen increases expression ISO RGD:732141 6480464 Oxygen deficiency results in increased expression of TXNIP mRNA CTD PMID:20880076 dorsomorphin multiple interactions ISO RGD:732141 6480464 dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]] CTD PMID:29031535 dorsomorphin multiple interactions ISO RGD:1343574 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:732141 6480464 Doxorubicin affects the expression of TXNIP mRNA CTD PMID:16243910 doxorubicin multiple interactions ISO RGD:1343574 6480464 MAPK1 inhibits the reaction [Doxorubicin results in decreased expression of TXNIP mRNA] CTD PMID:24885895 doxorubicin decreases expression ISO RGD:1343574 6480464 Doxorubicin results in decreased expression of TXNIP mRNA CTD PMID:24885895 , PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of TXNIP mRNA CTD PMID:29391264 enniatin increases expression ISO RGD:1343574 6480464 enniatins results in increased expression of TXNIP mRNA CTD PMID:31100301 enniatin multiple interactions ISO RGD:1343574 6480464 [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA more ... CTD PMID:31904472 , PMID:34015425 entinostat decreases expression ISO RGD:1343574 6480464 entinostat results in decreased expression of TXNIP mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1343574 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNIP mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:732141 6480464 epoxiconazole results in decreased expression of TXNIP mRNA CTD PMID:35436446 estriol decreases expression ISO RGD:732141 6480464 Estriol results in decreased expression of TXNIP mRNA CTD PMID:25575267 ethanol multiple interactions ISO RGD:732141 6480464 FOXO1 protein inhibits the reaction [Ethanol results in increased expression of TXNIP protein] CTD PMID:32492475 ethanol multiple interactions ISO RGD:1343574 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNIP mRNA CTD PMID:29432896 ethanol increases expression ISO RGD:732141 6480464 Ethanol results in increased expression of TXNIP protein CTD PMID:32492475 ethyl methanesulfonate increases expression ISO RGD:1343574 6480464 Ethyl Methanesulfonate results in increased expression of TXNIP mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1343574 6480464 Etoposide results in increased expression of TXNIP protein CTD PMID:18270325 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of TXNIP mRNA CTD PMID:17264098 fenofibrate increases expression ISO RGD:1343574 6480464 Fenofibrate results in increased expression of TXNIP mRNA CTD PMID:25572481 fenpyroximate decreases expression ISO RGD:1343574 6480464 fenpyroximate results in decreased expression of TXNIP mRNA CTD PMID:33512557 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of TXNIP mRNA CTD PMID:34044035 fluoranthene multiple interactions ISO RGD:732141 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TXNIP mRNA CTD PMID:28329830 fluoranthene decreases expression ISO RGD:732141 6480464 fluoranthene results in decreased expression of TXNIP mRNA CTD PMID:28329830 flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of TXNIP mRNA CTD PMID:28263823 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of TXNIP mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:1343574 6480464 Folic Acid results in increased expression of TXNIP mRNA CTD PMID:11723236 folic acid decreases expression ISO RGD:1343574 6480464 Folic Acid results in decreased expression of TXNIP mRNA CTD PMID:21867686 formaldehyde increases expression ISO RGD:1343574 6480464 Formaldehyde results in increased expression of TXNIP mRNA CTD PMID:23649840 fructose increases expression EXP 6480464 Fructose results in increased expression of TXNIP protein CTD PMID:24491314 fructose multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Fructose results in increased expression of TXNIP protein], Quercetin inhibits the reaction [Fructose results in increased expression of TXNIP protein] CTD PMID:24491314 furan increases methylation EXP 6480464 furan results in increased methylation of TXNIP gene CTD PMID:22079235 galactose increases expression ISO RGD:1343574 6480464 Galactose results in increased expression of TXNIP protein CTD PMID:29426000 galactose multiple interactions ISO RGD:1343574 6480464 Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]], Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein] CTD PMID:29426000 Ganoderic acid A multiple interactions ISO RGD:732141 6480464 ganoderic acid A inhibits the reaction [Cyclophosphamide results in increased expression of TXNIP protein] CTD PMID:30506662 gedunin decreases expression ISO RGD:1343574 6480464 gedunin results in decreased expression of TXNIP mRNA CTD PMID:17010675 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of TXNIP mRNA CTD PMID:22061828 , PMID:33387578 glucose multiple interactions ISO RGD:1343574 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 glucose increases expression ISO RGD:732141 6480464 Glucose results in increased expression of TXNIP mRNA, Glucose results in increased expression of TXNIP protein CTD PMID:17178593 more ... glucose decreases expression ISO RGD:1343574 6480464 Glucose deficiency results in decreased expression of TXNIP mRNA, Glucose deficiency results in decreased expression of TXNIP protein CTD PMID:20195491 glucose multiple interactions ISO RGD:732141 6480464 [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein more ... CTD PMID:17178593 more ... glucose increases activity EXP 6480464 Glucose results in increased activity of TXNIP mRNA CTD PMID:21832250 glucose multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 , PMID:29031534 glucose increases expression ISO RGD:1343574 6480464 Glucose results in increased expression of TXNIP protein CTD PMID:23647015 glucose increases response to substance EXP 6480464 TXNIP mRNA results in increased susceptibility to Glucose CTD PMID:23647015 glucose increases expression EXP 6480464 Glucose results in increased expression of TXNIP protein CTD PMID:17178593 more ... glucose increases response to substance ISO RGD:1343574 6480464 TXNIP mRNA results in increased susceptibility to Glucose CTD PMID:23647015 hexadecanoic acid increases expression ISO RGD:732141 6480464 Palmitic Acid results in increased expression of TXNIP protein CTD PMID:29031535 hexadecanoic acid multiple interactions ISO RGD:732141 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein] more ... CTD PMID:29031535 hydrogen peroxide affects expression ISO RGD:1343574 6480464 Hydrogen Peroxide affects the expression of TXNIP mRNA CTD PMID:20044591 hydrogen peroxide increases response to substance ISO RGD:732141 6480464 TXNIP results in increased susceptibility to Hydrogen Peroxide CTD PMID:10843682 hydrogen peroxide increases expression ISO RGD:732141 6480464 Hydrogen Peroxide results in increased expression of TXNIP mRNA CTD PMID:10843682 hydrogen peroxide multiple interactions ISO RGD:732141 6480464 TXNIP promotes the reaction [Hydrogen Peroxide results in increased activity of MAPK8 protein], TXNIP promotes the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA] CTD PMID:10843682 hydrogen sulfide increases expression ISO RGD:732141 6480464 Hydrogen Sulfide results in increased expression of TXNIP mRNA CTD PMID:31843631 hydroxychloroquine multiple interactions ISO RGD:1343574 6480464 Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]] CTD PMID:29426000 indometacin decreases expression ISO RGD:1343574 6480464 Indomethacin results in decreased expression of TXNIP mRNA CTD PMID:16984733 ionomycin decreases expression ISO RGD:732141 6480464 Ionomycin results in decreased expression of TXNIP mRNA CTD PMID:10843682 irinotecan increases expression ISO RGD:1343574 6480464 Irinotecan results in increased expression of TXNIP mRNA CTD PMID:20185912 iron atom multiple interactions ISO RGD:732141 6480464 [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP mRNA, [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP protein CTD PMID:33393188 iron dextran multiple interactions ISO RGD:732141 6480464 [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP mRNA, [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP protein CTD PMID:33393188 iron(0) multiple interactions ISO RGD:732141 6480464 [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP mRNA, [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP protein CTD PMID:33393188 iron(III) nitrilotriacetate increases methylation EXP 6480464 ferric nitrilotriacetate results in increased methylation of TXNIP promoter CTD PMID:15834431 iron(III) nitrilotriacetate decreases expression EXP 6480464 ferric nitrilotriacetate results in decreased expression of TXNIP protein CTD PMID:15834431 isobutanol multiple interactions ISO RGD:1343574 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXNIP mRNA CTD PMID:29432896 isoprenaline multiple interactions EXP 6480464 Lutein inhibits the reaction [Isoproterenol results in increased expression of TXNIP protein] CTD PMID:34435724 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of TXNIP protein CTD PMID:34435724 ketamine increases expression EXP 6480464 Ketamine results in increased expression of TXNIP mRNA CTD PMID:20080153 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of TXNIP mRNA CTD PMID:15372504 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of TXNIP mRNA CTD PMID:22641619 Licochalcone B decreases expression ISO RGD:1343574 6480464 licochalcone B results in decreased expression of TXNIP mRNA CTD PMID:33647349 lipopolysaccharide decreases expression ISO RGD:732141 6480464 Lipopolysaccharides results in decreased expression of TXNIP mRNA CTD PMID:26582142 lutein multiple interactions EXP 6480464 Lutein inhibits the reaction [Isoproterenol results in increased expression of TXNIP protein] CTD PMID:34435724 menadione affects expression ISO RGD:1343574 6480464 Vitamin K 3 affects the expression of TXNIP mRNA CTD PMID:20044591 metformin multiple interactions ISO RGD:1343574 6480464 Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]], Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein] CTD PMID:29426000 metformin multiple interactions ISO RGD:732141 6480464 Metformin inhibits the reaction [Glucose results in increased expression of TXNIP mRNA] CTD PMID:31974165 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of TXNIP mRNA CTD PMID:30467583 methotrexate increases expression ISO RGD:1343574 6480464 Methotrexate results in increased expression of TXNIP mRNA CTD PMID:19192274 methyl methanesulfonate increases expression ISO RGD:1343574 6480464 Methyl Methanesulfonate results in increased expression of TXNIP mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1343574 6480464 methylmercuric chloride results in decreased expression of TXNIP mRNA CTD PMID:23179753 , PMID:28001369 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of TXNIP mRNA CTD PMID:17905399 mono(2-ethylhexyl) phthalate affects expression ISO RGD:732141 6480464 mono-(2-ethylhexyl)phthalate affects the expression of TXNIP mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO RGD:732141 6480464 monobutyl phthalate affects the expression of TXNIP mRNA CTD PMID:21195148 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of TXNIP mRNA CTD PMID:21515302 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1343574 6480464 N more ... CTD PMID:19013360 N-acetylsphingosine increases expression ISO RGD:1343574 6480464 N-acetylsphingosine results in increased expression of TXNIP protein CTD PMID:18270325 N-acetylsphingosine increases expression ISO RGD:732141 6480464 N-acetylsphingosine results in increased expression of TXNIP mRNA, N-acetylsphingosine results in increased expression of TXNIP protein CTD PMID:18270325 N-acetylsphingosine multiple interactions ISO RGD:1343574 6480464 TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein] more ... CTD PMID:18270325 N-ethyl-5'-carboxamidoadenosine increases activity EXP 6480464 Adenosine-5'-(N-ethylcarboxamide) results in increased activity of TXNIP mRNA CTD PMID:21832250 N-methyl-4-phenylpyridinium decreases expression ISO RGD:732141 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TXNIP mRNA CTD PMID:17475336 , PMID:18069091 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TXNIP mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1343574 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TXNIP mRNA CTD PMID:24810058 naphthalenes decreases expression EXP 6480464 Naphthalenes results in decreased expression of TXNIP protein CTD PMID:17337753 nickel dichloride increases expression ISO RGD:1343574 6480464 nickel chloride results in increased expression of TXNIP mRNA CTD PMID:17312168 nickel sulfate decreases expression ISO RGD:1343574 6480464 nickel sulfate results in decreased expression of TXNIP mRNA CTD PMID:22714537 nicotine increases expression ISO RGD:732141 6480464 Nicotine results in increased expression of TXNIP mRNA CTD PMID:17456735 NMN zwitterion multiple interactions ISO RGD:732141 6480464 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of TXNIP protein] CTD PMID:30292833 NMN zwitterion multiple interactions EXP 6480464 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of TXNIP mRNA], Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of TXNIP protein] CTD PMID:30292833 nobiletin decreases expression ISO RGD:1343574 6480464 nobiletin results in decreased expression of TXNIP mRNA, nobiletin results in decreased expression of TXNIP protein CTD PMID:23321314 nobiletin decreases expression EXP 6480464 nobiletin results in decreased expression of TXNIP mRNA, nobiletin results in decreased expression of TXNIP protein CTD PMID:23321314 ochratoxin A multiple interactions ISO RGD:1343574 6480464 [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA more ... CTD PMID:34015425 ochratoxin A increases expression ISO RGD:1343574 6480464 ochratoxin A results in increased expression of TXNIP mRNA CTD PMID:34015425 ozone multiple interactions ISO RGD:732141 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TXNIP mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TXNIP mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:732141 6480464 Acetaminophen affects the expression of TXNIP mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of TXNIP mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1343574 6480464 Acetaminophen results in decreased expression of TXNIP mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:1343574 6480464 Acetaminophen affects the expression of TXNIP mRNA CTD PMID:25704631 paraquat increases response to substance ISO RGD:1343574 6480464 TXNIP protein results in increased susceptibility to Paraquat CTD PMID:12054598 paraquat increases expression ISO RGD:732141 6480464 Paraquat results in increased expression of TXNIP mRNA, Paraquat results in increased expression of TXNIP protein CTD PMID:21463325 , PMID:29054699 paraquat multiple interactions ISO RGD:732141 6480464 Silymarin inhibits the reaction [Paraquat results in increased expression of TXNIP protein] CTD PMID:29054699 perfluorobutyric acid decreases expression ISO RGD:1343574 6480464 perfluorobutyric acid results in decreased expression of TXNIP mRNA CTD PMID:23567314 perfluorodecanoic acid increases expression ISO RGD:1343574 6480464 perfluorodecanoic acid results in increased expression of TXNIP mRNA CTD PMID:23567314 perfluorododecanoic acid affects expression ISO RGD:1343574 6480464 perfluorododecanoic acid affects the expression of TXNIP mRNA CTD PMID:23567314 perfluoroheptanoic acid increases expression ISO RGD:1343574 6480464 perfluoro-n-heptanoic acid results in increased expression of TXNIP mRNA CTD PMID:23567314 perfluorohexanesulfonic acid affects expression ISO RGD:1343574 6480464 perfluorohexanesulfonic acid affects the expression of TXNIP mRNA CTD PMID:23567314 perfluorohexanoic acid increases expression ISO RGD:1343574 6480464 perfluorohexanoic acid results in increased expression of TXNIP mRNA CTD PMID:23567314 perfluorononanoic acid increases expression ISO RGD:1343574 6480464 perfluoro-n-nonanoic acid results in increased expression of TXNIP mRNA CTD PMID:23567314 , PMID:32588087 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1343574 6480464 perfluorooctane sulfonic acid affects the expression of TXNIP mRNA CTD PMID:23567314 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of TXNIP mRNA CTD PMID:16221955 , PMID:28511854 perfluorooctanoic acid decreases expression ISO RGD:1343574 6480464 perfluorooctanoic acid results in decreased expression of TXNIP protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO RGD:1343574 6480464 perfluorooctanoic acid results in increased expression of TXNIP mRNA, perfluorooctanoic acid results in increased expression of TXNIP protein CTD PMID:23567314 more ... perfluoroundecanoic acid affects expression ISO RGD:1343574 6480464 perfluoroundecanoic acid affects the expression of TXNIP mRNA CTD PMID:23567314 phenethyl isothiocyanate increases expression ISO RGD:1343574 6480464 phenethyl isothiocyanate results in increased expression of TXNIP mRNA CTD PMID:26678675 phenformin increases expression EXP 6480464 Phenformin results in increased expression of TXNIP mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of TXNIP mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:732141 6480464 Phenobarbital results in decreased expression of TXNIP mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO RGD:732141 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TXNIP mRNA] CTD PMID:19482888 phenylmercury acetate multiple interactions ISO RGD:1343574 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNIP mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:1343574 6480464 picoxystrobin results in decreased expression of TXNIP mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:732141 6480464 pirinixic acid results in increased expression of TXNIP mRNA CTD PMID:17426115 more ... piroxicam multiple interactions ISO RGD:1343574 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNIP mRNA] CTD PMID:21858171 piroxicam increases expression ISO RGD:1343574 6480464 Piroxicam results in increased expression of TXNIP mRNA CTD PMID:19192274 piroxicam decreases expression ISO RGD:1343574 6480464 Piroxicam results in decreased expression of TXNIP mRNA CTD PMID:21858171 potassium dichromate increases expression ISO RGD:1343574 6480464 Potassium Dichromate results in increased expression of TXNIP protein CTD PMID:23718831 prednisolone increases expression ISO RGD:1343574 6480464 Prednisolone results in increased expression of TXNIP mRNA CTD PMID:19192274 progesterone decreases expression ISO RGD:1343574 6480464 Progesterone results in decreased expression of TXNIP mRNA CTD PMID:18037150 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of TXNIP mRNA CTD PMID:20726854 propiconazole decreases expression ISO RGD:732141 6480464 propiconazole results in decreased expression of TXNIP mRNA CTD PMID:21278054 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of TXNIP mRNA CTD PMID:28970091 pyrimidifen decreases expression ISO RGD:1343574 6480464 pyrimidifen results in decreased expression of TXNIP mRNA CTD PMID:33512557 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Fructose results in increased expression of TXNIP protein] more ... CTD PMID:23647015 , PMID:24491314 quercetin decreases expression ISO RGD:1343574 6480464 Quercetin results in decreased expression of TXNIP mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:1343574 6480464 Quercetin inhibits the reaction [Glucose results in increased expression of TXNIP protein] CTD PMID:23647015 quinolin-8-ol increases expression ISO RGD:1343574 6480464 Oxyquinoline results in increased expression of TXNIP mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1343574 6480464 Lactic Acid results in increased expression of TXNIP mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1343574 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of TXNIP mRNA CTD PMID:19059307 reactive oxygen species multiple interactions ISO RGD:732141 6480464 Glucosamine promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species], Glucose promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species] CTD PMID:17178593 reactive oxygen species increases abundance ISO RGD:732141 6480464 TXNIP results in increased abundance of Reactive Oxygen Species CTD PMID:17178593 reactive oxygen species multiple interactions EXP 6480464 TXNIP protein promotes the reaction [AGT protein results in increased abundance of Reactive Oxygen Species] CTD PMID:15123525 resveratrol decreases expression ISO RGD:1343574 6480464 resveratrol results in decreased expression of TXNIP mRNA, resveratrol results in decreased expression of TXNIP protein CTD PMID:19371625 , PMID:20195491 resveratrol multiple interactions ISO RGD:732141 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of TXNIP mRNA] CTD PMID:31298478 resveratrol decreases expression ISO RGD:732141 6480464 resveratrol results in decreased expression of TXNIP protein CTD PMID:20195491 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of TXNIP protein CTD PMID:20195491 resveratrol increases expression ISO RGD:1343574 6480464 resveratrol results in increased expression of TXNIP protein CTD PMID:20195491 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of TXNIP protein CTD PMID:20195491 rotenone increases expression EXP 6480464 Rotenone results in increased expression of TXNIP mRNA CTD PMID:19013527 , PMID:28374803 rotenone decreases expression ISO RGD:1343574 6480464 Rotenone results in decreased expression of TXNIP mRNA CTD PMID:24810058 more ... S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1343574 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of TXNIP mRNA CTD PMID:33725128 Salidroside multiple interactions EXP 6480464 rhodioloside inhibits the reaction [Glucose results in increased expression of TXNIP protein] CTD PMID:29031534 SB 431542 multiple interactions ISO RGD:1343574 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Securinine decreases expression ISO RGD:1343574 6480464 securinine results in decreased expression of TXNIP mRNA CTD PMID:32662633 silicon dioxide increases expression ISO RGD:1343574 6480464 Silicon Dioxide analog results in increased expression of TXNIP mRNA, Silicon Dioxide results in increased expression of TXNIP mRNA CTD PMID:22300531 more ... silicon dioxide affects expression ISO RGD:1343574 6480464 Silicon Dioxide analog affects the expression of TXNIP mRNA CTD PMID:23806026 silicon dioxide decreases expression ISO RGD:1343574 6480464 Silicon Dioxide results in decreased expression of TXNIP mRNA CTD PMID:23623845 silicon dioxide decreases expression ISO RGD:732141 6480464 Silicon Dioxide results in decreased expression of TXNIP mRNA CTD PMID:19073995 , PMID:33720480 silver atom decreases expression ISO RGD:1343574 6480464 Silver results in decreased expression of TXNIP mRNA CTD PMID:26014281 silver atom increases expression ISO RGD:732141 6480464 Silver results in increased expression of TXNIP mRNA CTD PMID:19429238 , PMID:22576574 silver(0) increases expression ISO RGD:732141 6480464 Silver results in increased expression of TXNIP mRNA CTD PMID:19429238 , PMID:22576574 silver(0) decreases expression ISO RGD:1343574 6480464 Silver results in decreased expression of TXNIP mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:1343574 6480464 sodium arsenite results in decreased expression of TXNIP mRNA CTD PMID:29301061 sodium arsenite increases expression ISO RGD:732141 6480464 sodium arsenite results in increased expression of TXNIP mRNA CTD PMID:36209798 sodium arsenite affects expression ISO RGD:1343574 6480464 sodium arsenite affects the expression of TXNIP mRNA CTD PMID:34032870 sodium aurothiomalate increases expression ISO RGD:1343574 6480464 Gold Sodium Thiomalate results in increased expression of TXNIP mRNA CTD PMID:19192274 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of TXNIP mRNA, Streptozocin results in increased expression of TXNIP protein CTD PMID:23647015 streptozocin increases expression ISO RGD:732141 6480464 Streptozocin results in increased expression of TXNIP mRNA CTD PMID:17582205 streptozocin multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Streptozocin results in increased expression of TXNIP mRNA] more ... CTD PMID:23647015 sunitinib decreases expression ISO RGD:1343574 6480464 Sunitinib results in decreased expression of TXNIP mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:1343574 6480464 [Tamoxifen co-treated with ESR1 protein] results in decreased expression of TXNIP mRNA CTD PMID:19059307 tamoxifen affects expression ISO RGD:732141 6480464 Tamoxifen affects the expression of TXNIP mRNA CTD PMID:20937368 tebufenpyrad decreases expression ISO RGD:1343574 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of TXNIP mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:1343574 6480464 Temozolomide results in increased expression of TXNIP mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1343574 6480464 tert-Butylhydroperoxide results in decreased expression of TXNIP mRNA CTD PMID:15336504 tert-butyl hydroperoxide decreases response to substance ISO RGD:732141 6480464 TXNIP protein results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:15003993 tert-butyl hydroperoxide increases expression ISO RGD:732141 6480464 tert-Butylhydroperoxide results in increased expression of TXNIP mRNA CTD PMID:14729362 more ... Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of TXNIP mRNA CTD PMID:21515302 testosterone enanthate affects expression ISO RGD:1343574 6480464 testosterone enanthate affects the expression of TXNIP mRNA CTD PMID:17440010 tetrachloroethene increases expression ISO RGD:732141 6480464 Tetrachloroethylene results in increased expression of TXNIP mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:732141 6480464 Carbon Tetrachloride affects the expression of TXNIP mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:1343574 6480464 Thapsigargin results in increased expression of TXNIP mRNA CTD PMID:29453283 thifluzamide decreases expression ISO RGD:1343574 6480464 thifluzamide results in decreased expression of TXNIP mRNA CTD PMID:33512557 thimerosal decreases expression ISO RGD:1343574 6480464 Thimerosal results in decreased expression of TXNIP mRNA CTD PMID:27188386 thioacetamide increases response to substance ISO RGD:732141 6480464 TXNIP protein results in increased susceptibility to Thioacetamide CTD PMID:20713078 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TXNIP mRNA CTD PMID:34492290 thioacetamide multiple interactions ISO RGD:732141 6480464 [TXNIP gene mutant form co-treated with Thioacetamide] results in increased expression of BCL2 protein more ... CTD PMID:20713078 titanium dioxide increases expression ISO RGD:732141 6480464 titanium dioxide results in increased expression of TXNIP mRNA CTD PMID:23557971 , PMID:31298478 titanium dioxide multiple interactions ISO RGD:732141 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of TXNIP mRNA] CTD PMID:31298478 topotecan affects response to substance ISO RGD:1343574 6480464 TXNIP protein affects the susceptibility to Topotecan CTD PMID:16217747 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of TXNIP mRNA CTD PMID:21683754 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of TXNIP mRNA CTD PMID:17905399 trichloroethene increases expression ISO RGD:732141 6480464 Trichloroethylene results in increased expression of TXNIP mRNA CTD PMID:25549359 , PMID:28973375 trichostatin A affects expression ISO RGD:1343574 6480464 trichostatin A affects the expression of TXNIP mRNA CTD PMID:28542535 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of TXNIP mRNA CTD PMID:30589522 Triptolide increases expression ISO RGD:1343574 6480464 triptolide results in increased expression of TXNIP protein CTD PMID:30394310 Triptolide multiple interactions ISO RGD:732141 6480464 NOTCH1 protein modified form inhibits the reaction [triptolide results in increased expression of TXNIP protein] CTD PMID:30394310 Triptolide increases expression ISO RGD:732141 6480464 triptolide results in increased expression of TXNIP protein CTD PMID:30394310 troglitazone decreases expression ISO RGD:732141 6480464 troglitazone results in decreased expression of TXNIP mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:1343574 6480464 troglitazone results in increased expression of TXNIP mRNA CTD PMID:25572481 , PMID:25669987 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of TXNIP mRNA CTD PMID:21515302 tunicamycin increases expression ISO RGD:1343574 6480464 Tunicamycin results in increased expression of TXNIP mRNA CTD PMID:29453283 urethane increases expression ISO RGD:1343574 6480464 Urethane results in increased expression of TXNIP mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:732141 6480464 Valproic Acid results in increased expression of TXNIP mRNA CTD PMID:15799026 , PMID:20546886 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of TXNIP mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1343574 6480464 Valproic Acid results in increased expression of TXNIP mRNA CTD PMID:28001369 valproic acid affects expression ISO RGD:732141 6480464 Valproic Acid affects the expression of TXNIP mRNA CTD PMID:26072468 valproic acid affects expression ISO RGD:1343574 6480464 Valproic Acid affects the expression of TXNIP mRNA CTD PMID:25979313 , PMID:26072468 valproic acid decreases expression ISO RGD:1343574 6480464 Valproic Acid results in decreased expression of TXNIP mRNA CTD PMID:23179753 verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP mRNA], Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP protein] CTD PMID:35460826 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of TXNIP mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TXNIP mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:1343574 6480464 Vincristine results in increased expression of TXNIP mRNA CTD PMID:23649840 vorinostat increases expression ISO RGD:1343574 6480464 Vorinostat results in increased expression of TXNIP mRNA, Vorinostat results in increased expression of TXNIP protein CTD PMID:17218635 , PMID:25812606 vorinostat multiple interactions ISO RGD:1343574 6480464 N-(oxo-5 more ... CTD PMID:25812606 zearalenone multiple interactions ISO RGD:1343574 6480464 [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of TXNIP mRNA more ... CTD PMID:34015425 zoledronic acid increases expression ISO RGD:1343574 6480464 zoledronic acid results in increased expression of TXNIP mRNA CTD PMID:20977926
